Related Experiment Video
Updated: Jun 6, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Cardiovascular disease and depression in women
1Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, 473 West 12th Avenue, Columbus, OH 43210, USA. Laxmi.Mehta@osumc.edu
Insights
Heart disease and depression are common, linked conditions. Research is needed to understand if treating depression in women with cardiovascular disease improves heart health outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Heart disease and depression are prevalent, often co-occurring conditions.
- These conditions were projected to be leading causes of global disability by 2020.
- Current cardiovascular disease secondary prevention trials have not demonstrated that depression treatment reduces cardiac events.
Purpose of the Study:
- To assess the association between cardiovascular disease and depression.
- To investigate biomarkers and novel treatment strategies for depression.
- To evaluate the impact of depression treatment on cardiovascular outcomes, particularly in women.
Main Methods:
- The abstract does not specify methods, but calls for clinical trials.
- Focus on diverse cardiovascular disease and depression subtypes in women.
- Exploration of biomarkers and treatment efficacy.
Main Results:
- No secondary prevention trials have shown depression treatment reduces cardiovascular events.
- The abstract highlights the need for further research rather than presenting results.
Conclusions:
- More clinical trials are essential to understand the complex relationship between heart disease and depression.
- Investigating specific biomarkers and tailored depression treatments is crucial.
- Determining if treating depression positively impacts cardiovascular outcomes requires further investigation.
Abstract:
Heart disease and depression are very common, frequently concomitant, conditions that were previously speculated by the World Health Organization to be the first and second leading causes of disability (respectively) by the year 2020. There have been no secondary prevention of cardiovascular disease trials that have shown treatment of depression reduces cardiovascular events. Women are different, all with diverse types of cardiovascular disease and depression, which likely respond to different treatments. More clinical trials are needed to further assess the association of cardiovascular disease and depression, investigate biomarkers and ways to treat depression, and evaluate if treatment of depression makes a positive impact on cardiovascular outcomes.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
